Inhibition of pSTAT1 by tofacitinib accounts for the early improvement of experimental chronic synovitis.

J Inflamm (Lond) · 2019 · PMC6352431 · PMID 30728752

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

approaching significancep = 0.07so close (0.05 < p ≤ 0.1)

This effect was not so pronounced in the TOFA-treated AIA group, with a difference between both groups approaching significance ( p = 0.07) (Fig. 1 b).

also in 2,640 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.